Bone Morphogenetic Protein 6 (BMP6) (Middle Region) Peptide
Quick Overview for Bone Morphogenetic Protein 6 (BMP6) (Middle Region) Peptide (ABIN973846)
Target
Origin
Source
Application
-
-
Protein Region
- Middle Region
-
Characteristics
- This is a synthetic peptide designed for use in combination with anti-BMP6 antibody (Catalog #: ARP58757_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
-
-
Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handling Advice
- Avoid repeated freeze-thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- BMP6 (Bone Morphogenetic Protein 6 (BMP6))
-
Background
-
The bone morphogenetic proteins (BMPs) are a family of secreted signaling molecules that can induce ectopic bone growth. Many BMPs are part of the transforming growth factor-beta (TGFB) superfamily. BMPs were originally identified by an ability of deminer
Alias Symbols: VGR, VGR1
Protein Interaction Partner: ACVR2A,BMPER,BMPR1A,BMPR1B,BMPR2,CHRDL2,NCOA3,SMAD5,SOSTDC1,ACVR2A,ACVR2B,BMPR1A,BMPR2
Protein Size: 513 -
Molecular Weight
- 57 kDa
-
Gene ID
- 654
-
NCBI Accession
- NM_001718, NP_001709
-
UniProt
- P22004
Target
-